← All companies

LFVN

LifeVantage Corporation

LFVN Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.58

+0.15 +2.33%

Key statistics

from XBRL data in SEC filings

Market cap

$83.0M

Revenue (TTM)

$195M

Net income (TTM)

$5.75M

EPS (TTM)

$0.46

P/E ratio

14.3

Dividend yield

2.74%

Free cash flow

$10.5M

Cash

$12.5M

Total assets

$62.1M

Gross margin

78.1%

52-week range

$3.90 – $15.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Aug 3, 2026 8-K Results of operations (earnings release) May 6, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Director or officer change Apr 16, 2026 8-K Results of operations (earnings release); Director or officer change Feb 4, 2026 10-Q Quarter ended 2025-12-31 Feb 4, 2026 8-K Director or officer change Dec 9, 2025 8-K Shareholder vote results Nov 12, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Sep 4, 2025 10-K Fiscal year ended 2025-06-30 Sep 4, 2025 8-K Results of operations (earnings release) May 6, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) Feb 5, 2025 10-Q Quarter ended 2024-12-31 Feb 5, 2025 8-K Modified rights of security holders; Amended charter or bylaws Nov 19, 2024 8-K Shareholder vote results Nov 14, 2024 8-K Results of operations (earnings release) Oct 29, 2024 10-Q Quarter ended 2024-09-30 Oct 29, 2024 8-K Results of operations (earnings release) Aug 28, 2024 10-K Fiscal year ended 2024-06-30 Aug 28, 2024 8-K Director or officer change Aug 26, 2024 8-K Results of operations (earnings release) May 2, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Entered a material agreement; Took on a direct financial obligation Apr 16, 2024 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Feb 15, 2024 8-K Results of operations (earnings release) Jan 30, 2024 10-Q Quarter ended 2023-12-31 Jan 30, 2024 8-K/A Shareholder vote results; Other events Nov 13, 2023 8-K Shareholder vote results Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Aug 31, 2023 8-K Results of operations (earnings release) Aug 28, 2023 10-K Fiscal year ended 2023-06-30 Aug 28, 2023 8-K Other events Aug 14, 2023 8-K Other events Jun 13, 2023 8-K Results of operations (earnings release) May 4, 2023 10-Q Quarter ended 2023-03-31 May 4, 2023